baber/WOPTO huggingface dataset:
Patent NZ-583276-A (NZ)
Title: Liquid formulations of granulocyte colony stimulating factor and polymer conjugates
Inventor: HINDERER WALTER
IPC: A61K47/48
Filed: 2008-08-27
Abstract: Disclosed is an aqueous preparation comprising a polymer-Granulocyte Colony Stimulating Factor (G-CSF) conjugate, wherein the preparation has a pH in the range of 4.5 to 5.5 and further comprises a surfactant and sodium in a concentration of less than 10 mmol/L, and wherein the preparation is free from tartaric acid and succinic acid and salts thereof.
Patent NZ-588114-A (NZ)
Title: Two-channel air conditioner for the flexible climate control of a number of rooms or zones
Inventor: BAUER ALBERT
IPC: F24F3/052
Filed: 2009-02-23
Abstract: A two-channel air-conditioner for the climate control of a number rooms and/or room zones is disclosed. The two-channel air-conditioner has an air inlet device in every room to be climate controlled, at least one pair of supply air channels, where at least one supply air channel comprises a cooling and/or heating register, and at least one temperature regulator. The temperature regulator keeps the room to be climate controlled at a set temperature. A valve unit is associated with at least each of the supply air channels where the valve unit connects the associated supply air channel with the respective air inlet device. The valve units are arranged independently from each other such that the air quantities from the respective air supply channels to the individual rooms to be climate controlled may be adjusted independently from each other, so that the maximum amount of input air from one input air channel as well as the maximum amount of input air from the other input air channel can be introduced into the room to be climate controlled.
Patent NZ-590631-A (NZ)
Title: Novel genes related to glutaminyl cyclase
Inventor: DEMUTH HANS-ULRICH
IPC: C07D417/12
Filed: 2007-09-21
Abstract: Provided are mammalian, insect of bacterial host cells genetically engineered to contain nucleic acids coding for glutaminyl-peptide cyclotransferase-like proteins which are isoenzymes of glutaminyl cyclase, with a specified amino acid sequence. Further provided are methods of screening compounds capable of inhibiting the enzyme activity.
Patent NZ-591181-A (NZ)
Title: Organoarsenic compounds and methods for the treatment of cancer
Inventor: SCHWARTZ BRIAN ERIC
IPC: A61K31/285
Filed: 2009-08-14
Abstract: Disclosed herein is a method for treating in a non-human animal a lymphoma selected from peripheral T-cell lymphoma (PTCL), diffuse large B-cell, marginal zone lymphoma, and Hodgkin's nodular sclerosis, comprising administering a compound having a structure of formula (I) or a pharmaceutically acceptable salt thereof, wherein the variables are defined in the specification. In one embodiment, formula (I) represents L-(+)-2-amino-3-(dimethylarsino)thio-3-methylbutanoic acid.
Patent NZ-593802-A (NZ)
Title: Plant extracts from acronychia species and their use
Inventor: GORDON VICTORIA ANNE
IPC: A23L27/12
Filed: 2009-12-23
Abstract: 593802 Disclosed is the use of an effective amount of an extract from the fruit of an Acronychia species, in the manufacture of a medicament for treating or preventing a bacterial infection, helmintic infection, a cell proliferative disorder, an inflammatory disease or disorder or a disorder related to oxidative stress; wherein the Acronychia species is selected from A. acidula, A. aberrans, A. acronychiodes and A. crassipetala. Further disclosed is a compound of formula (II), wherein the substituents are as described within the specification. Also disclosed is a cosmetic or fragrance composition comprising an extract from the fruit of an Acronychia species.
Patent NZ-596565-A (NZ)
Title: Methods, devices and systems for identifying an individual to a pre-defined group
Inventor: SNYDER JULIA ANN
IPC: A41D13/12
Filed: 2010-04-30
Abstract: 596565 A garment 300 with a defining characteristic that helps identifying an individual in a group. The garment 300 comprises a material having fabric stitching visible from an external position. The stitching forms a set of repeating source identifying indicia 310. When worn, the garment 300 displays the indicia 310 in a manner such that at least one of the indicia 310 is visible from substantially all elevation perspectives. The garment helps identify an individual in a group
Patent NZ-597267-A (NZ)
Title: A method for production of an alcoholic beverage with reduced content of alcohol
Inventor: BJERRE KRISTINE
IPC: C12C5/00
Filed: 2010-07-06
Abstract: Disclosed is a method for production of an alcoholic beverage with reduced content of alcohol, comprising the following steps: (1) treating unfermented beverage starting solution with an effective amount of the following two enzymes: (a) glucose oxidase in the presence of oxygen for a period of time adequate to convert at least a portion of the glucose in the solution into gluconic acid; and (b) glucose isomerase for a period of time adequate to convert at least a portion of the fructose in the solution into glucose; and thereafter, (2) fermenting said treated solution with reduced amounts of glucose and fructose to obtain the alcoholic beverage with reduced content of alcohol; with the proviso that the beverage starting solution is NOT grape juice.
Patent NZ-599746-A (NZ)
Title: A system for packaging, processing, activating, and deactivating multiple individual transaction cards as a singular unit
Inventor: SINGH LALIT
IPC: G06K5/00
Filed: 2007-11-09
Abstract: 599746 Disclosed is an automated method for the secure processing of transaction cards (203) at a point of sale. The method includes providing a plurality of transaction cards (203), each with a unique identifier (111), assembled into a package (200). Each unique identifier (111) is associated to a unique account. The package (200) is provided or associated with at least three distinct identifiers and a unique package identifier (250). A vendor product identification code identifier and a combination identifier (neither shown) are further assigned to the package (200). The combination identifier comprises both the vendor product identification code identifier and the unique package identifier (250). The method also includes associating the unique identifier of the package (250) with the unique account identifiers of the individual transaction cards (203) assembled in the package (200) and compiling a database of associated unique package identifiers and unique account identifiers. A transaction card processing system (not shown) is used to effect the secure processing of transaction cards (203). The transaction card processing system comprises a point of sale component and multi-card transaction computer component. A secure connection between the components of the transaction card processing system is also used in the performance of the method. The method includes accessing the database upon receipt of a request to activate or deactivate the package (200), wherein the request may comprise either a one-step or a two-step sequence. The information contained in the database is processed upon receipt of a request to activate or deactivate the package (200). The method further includes initiating an activation or deactivation protocol for the individual transaction cards (203) contained in the package (200), wherein the activation or deactivation protocol comprises conveying a request for transaction card (203) activation or deactivation to an individual transaction card issuer's authorisation system to effect activation or deactivation of the individual transaction cards (203). Activation or deactivation of the individual transaction cards (203) is then received from the individual transaction card issuer's authorisation system. The method further includes generating and maintaining a transaction log of activities performed involving the multi-card transaction computer and generating and maintaining an error log of activities unsuccessfully completed involving the multi-card transaction computer. The transaction log and error log are generated and maintained by the multi-card transaction computer. The method further includes communicating the activation or deactivation of the individual transaction cards (203) to the point of sale.
Patent NZ-600107-A (NZ)
Title: Formulations, salts and polymorphs of transnorsertraline and uses thereof
Inventor: BONASIA PHILIP JAMES
IPC: C07C211/42
Filed: 2010-12-03
Abstract: Disclosed herein is a pharmaceutical composition comprising transnorsertraline or pharmaceutically acceptable salt or solvate thereof, and mannitol or xylitol, the composition may further comprise talc, kaolin or bentonite, and magnesium stearate, calcium stearate, zinc stearate, or stearic acid. Preferably, the composition comprises a hydrochloride salt of transnorsertraline or a hydrate thereof, mannitol, magnesium stearate, talc and sodium starch glycolate. These compositions are is solid dosage form exhibit chemical and physical stability for considerably long duration.
Patent NZ-600690-A (NZ)
Title: Fkbp-l and uses thereof
Inventor: HIRST DAVID
IPC: A61K31/00
Filed: 2007-06-08
Abstract: NZ 600690 Disclosed is an isolated polypeptide which comprises the amino acid sequence as shown in SEQ ID NO: 10, or a biologically active fragment thereof, or a sequence at least 90% identical to SEQ ID NO: 10 or said fragment thereof, wherein said polypeptide includes no more than 200 consecutive amino acids of the amino acid sequence shown in SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO: 29, wherein said polypeptide exhibits anti-angiogenic activity, and wherein the sequences are as defined in the complete specification.
Patent NZ-601860-A (NZ)
Title: Production of polypeptides
Inventor: DRAPEAU DENIS
IPC: C12P21/02
Filed: 2005-08-26
Abstract: 601860 Disclosed is a method of producing a polypeptide in a large-scale production cell culture comprising the steps of: providing a cell culture comprising; mammalian cells that contain a gene encoding a polypeptide of interest, which gene is expressed under condition of cell culture; and a medium containing glutamine, having a cumulative amino acid amount per unit volume greater than about 70 mM, a molar cumulative glutamine to cumulative asparagine ratio of less than about 2, and having a medium characteristic selected from the group consisting of (i) a molar cumulative glutamine to cumulative total amino acid ratio ofless than about 0.2, (ii) a molar cumulative inorganic ion to cumulative total amino acid ratio between about 0.4 to 1, and (iii) a combined cumulative amount of glutamine and asparagine per unit volume of greater than about 16 mM, and combinations thereof; wherein the cumulative total amount of histidine, isoleucine, leucine, methionine, phenylalanine, tryptophan, tyrosine, and proline per unit volume in said medium is greater than approximately 25 mM; maintaining said culture in an initial growth phase under a first set of culture conditions for a first period of time sufficient to allow said cells to reproduce to a viable cell density within a range of about 20%-80% of the maximal possible viable cell density if said culture were maintained under the first set of culture conditions; changing at least one of the culture conditions, so that a second set of culture conditions is applied; maintaining said culture for a second period of time under the second set of conditions and for a second period of time so that the polypeptide accumulates in the cell culture, provided that the polypeptide is not a TNFR-Fc, TNFR-Ig or an antibody to a ABeta fragment of amyloid precursor protein.
Patent NZ-608939-A (NZ)
Title: Fluid treatment apparatus
Inventor: WIERZBICKI DOMINIC
IPC: C02F1/32
Filed: 2011-08-30
Abstract: 608939 Disclosed is a UV fluid treatment apparatus. Fluids such as drinking water are treated with UV light rather than chemicals to disinfect water by eliminating harmful bacteria and viruses. The use of chemicals can lead to the formation of undesirable by-products. The UV fluid treatment apparatus comprises a housing (12); a treatment chamber (25); a UV lamp (34); a flow sensor (76); a power supply system and a control system. The treatment chamber (25) is defined within the housing (12) and includes an inlet and an outlet (24) to permit fluid flow through the treatment chamber (25). The UV lamp (34) is disposed within the treatment chamber (25). The flow sensor (76) is located externally of the treatment chamber (25) and it is separated from the treatment chamber (25) by a metal plate. The metal plate defines part of the surfaces defining the treatment chamber (25). The flow sensor (76) is operable through the plate to sense and determine the fluid flow rate across the plate and thereby generate a signal which is indicative of flow rate through the treatment chamber (25). The power supply system and the control system enable and control operation of the apparatus, wherein fluid entering and flowing through the treatment chamber (25) is disinfected by exposure to UV light generated by the UV lamp (34).
Patent NZ-609769-A (NZ)
Title: Diterpenoid derivatives endowed of biological properties
Inventor: CERRI ALBERTO
IPC: C07D211/46
Filed: 2011-10-26
Abstract: The disclosure relates to diterpenoid derivatives of general formula (I) wherein the various functional groups are defined within the specification. The disclosure also relates to pharmaceutical compositions containing them and methods of preparing them. Finally, the disclosure also relates to the use of these compounds for treatment, or for the manufacture of a medicament for the treatment, of cardiovascular disorders, urinary incontinence, asthma, or Alzheimer’s disease and/or to prevent obstructive vascular lesions consequently to arteriotomy and/or angioplasty, and to prevent organ damage in hypertensive patients.
Patent NZ-615181-A (NZ)
Title: A shearing comb
Inventor: SELWYN WILLIAMS
IPC: B26B19/24
Filed: 2013-09-05
Abstract: Disclosed is a shearing comb particularly suitable for use with an apparatus for shearing sheep. The comb has a comb body (12) having forward (34) and rear (36) surfaces, and a plurality of spaced apart teeth (16, 48) formed integrally therewith and projecting forwardly from the forward surface (34). The comb body (12) further comprises at least one channel (46a, 46b) that extends from the forward surface (34) toward the rear surface (36) of the comb body (12). The comb body further comprises a pair of screw receiving recesses that project forwardly from the rear surface and the or each channel extend rearward beyond a forward most point of the screw receiving recess. The channel(s) act to minimise the build-up of lanolin or any other waxy material on the bottom surface (26) of the comb body (12).
Patent NZ-616639-A (NZ)
Title: Method and apparatus for removing artifacts from aerial images
Inventor: MA ZHENKUI
IPC: G06T5/00
Filed: 2012-06-20
Abstract: A computer system for creating artifact-free aerial images of a region of interest. A computer system receives one or more input aerial images that are obtained at different times. A false-color image is created by applying two or more of the input aerial images to different color channel inputs of the false-color image. Based on the color of the pixels in the false-color image, pixels in the two or more input aerial images are classified as representing clear, cloud or shadow areas. An output image is created by combining pixels that are classified as representing clear areas from two or more of the input aerial images.
Patent NZ-625927-A (NZ)
Title: Totarol extract formulations and uses thereof
Inventor: DOUGLAS ANTHONY MENDE
IPC: A61P31/02
Filed: 2013-03-07
Abstract: Provided are aqueous totarol extract formulations. Totarol is also known as (4bS,8aS)-1-isopropyl-4b,8,8-trimethyl-4b,5,6,7,8,8a,9,10-octahydrophenanthren-2-ol or (4bS)-trans-8,8-Trimethyl-4b,5,6,7,8,8a,9,10-octahydro-1-isopropylphenanthren-2-ol. An exemplified formulation comprises: (a) at least one emollient from 0.1-20% w/w; (b) totarol extract from 0.0005-20% w/w; (c) at least one surfactant from 0.3-40.0% w/w; (d) at least one GRAS solvent from 0.3-35.0% w/w; and (e) water q.s. 100. Further provided is the use of the formulations in wound healing and in the treatment of mastitis, metritis, endometritis and wound infections.
Patent NZ-628871-A (NZ)
Title: Substituted 6-amino-nicotinamides as kcnq2/3 modulators
Inventor: KÜHNERT SVEN
IPC: C07D413/14
Filed: 2011-10-19
Abstract: Provided are substituted 6-amino-nicotinamide compounds of the general formula (I), wherein the variables are as defined in the specification. Examples of the compounds include N-[(3,5-Difluoro-phenyl)-methyl]-2-ethylsulfanyl-4-methyl-6-morpholin-4-ylpyridine-3-carboxylic acid amide and N-(4,4-Dimethyl-pentyl)-4-methyl-6-morpholin-4-yl-2-tetrahydro-pyran-4-ylpyridine-3-carboxylic acid amide. The compounds are modulators of voltage gated potassium (K+) channels KCNQ2/3 (Kv7.2/7.3). The compounds may be useful in the treatment of pain and neurological disorders.
Patent NZ-700872-A (NZ)
Title: Prophylactic or therapeutic agent for giant cell tumors occurring in bone and soft tissue or for chondrosarcoma
Inventor: TAKEUCHI AKIHIKO
IPC: G01N33/52
Filed: 2013-03-18
Abstract: The present invention relates to the induction of PPARγ in giant cell tumours that occur in bone and soft tissue, or in chondrosarcoma. Specifically provided is the use of a non-steroidal anti-inflammatory agent selected from the group consisting of zaltoprofen, diclofenac, indomethacin, oxaprozin, acetaminophen, and ketoprofen, in the manufacture of a pharmaceutical composition, for prevention or treatment of giant cell tumors occurring in bone and soft tissue or chondrosarcoma.
Patent NZ-701982-A (NZ)
Title: Catechol o-methyltransferase activity inhibiting compounds
Inventor: AHLMARK MARKO
IPC: C07D333/60
Filed: 2013-05-23
Abstract: Compounds of formula (I), wherein R1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors.
Patent NZ-706941-A (NZ)
Title: Hydrocarbyl soluble quaternary ammonium caboxylates and fuel compositions containing them
Inventor: XINGGAO FANG
IPC: F02B47/00
Filed: 2015-04-13
Abstract: A fuel additive composition, fuel composition, method of improving the injector performance of a fuel injected engine, method for preventing or cleaning up deposits in an engine or fuel system, method of reducing wear in a fuel system of an engine, and method of improving the demulsibility of a fuel composition. The fuel composition includes from about 5 to about 300 ppm by weight based on a total weight of the fuel composition of a hydrocarbyl soluble quaternary ammonium carboxylate derived from a quaternary ammonium carbonate and an organic acid.
Patent NZ-714909-A (NZ)
Title: Polystyrene-phenolic foam composites
Inventor: BRACEGIRDLE WREN
IPC: C09K21/14
Filed: 2014-05-07
Abstract: Polystyrene-phenolic foam composites and precursor compositions comprising expandable polystyrene particles, phenolic resole resin, expandable thermoplastic microspheres, and acidic catalyst are disclosed. The composites exhibit excellent flame resistance properties and may be suitably prepared in standard expanded polystyrene processing equipment.
Patent NZ-716126-A (NZ)
Title: Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes
Inventor: CHEN YAN
IPC: G01N33/563
Filed: 2014-06-20
Abstract: The invention provides methods and compositions for identifying binding polypeptides (e.g., antibodies or antigen binding fragments thereof) that specifically binds to a cell-surface antigen. The methods of the invention generally comprise contacting a variegated DNA-display library of binding polypeptides with a cell-surface antigen displayed on the exterior surface of a live cell; and isolating from the library at least one library member that specifically binds to the cell-surface antigen on the exterior surface of the cell. Additionally, a restriction enzyme can be used to recover the full length binding polypeptides from the surface of the cells.
Patent NZ-717427-A (NZ)
Title: Machine for inflating and sealing an inflatable web
Inventor: LEPINE JASON
IPC: B65H23/032
Filed: 2014-09-15
Abstract: A machine (10) for inflating and sealing an inflatable web, the web including opposing longitudinal edges and a pair of sheets sealed together by transverse seals that form a series of inflatable containers. The machine (10) generally includes a support structure (12), a spool (18) for supporting a roll of the inflatable web, a web conveyance system (20), an inflation system (22) to inflate the containers, and a sealing device (24) for sealing closed the openings of the containers. If excessive force is applied when loading new film rolls onto the spools of the machines, the impact of the roll on the machine at the proximal end of the spool can damage the machine. Such damage will most often be manifested at actuator (138), particularly if that actuator is rigidly coupled to engagement member (134). The invention provides a positioning mechanism (132) whereby engagement member (134) and actuator (138) are configured such that the two separate from one another when a force, e.g. as exerted by roll (28) on engagement member (134), exceeds a predetermined amount.
Patent NZ-719368-A (NZ)
Title: Combination therapy of antibodies against human csf-1r and uses thereof
Inventor: CANNARILE MICHAEL
IPC: C07K16/28
Filed: 2013-03-08
Abstract: The use of an antibody binding to human CSF-1R for the manufacture of a medicament for use in the treatment of cancer wherein the antibody is administered in combination with a bispecific ANG-2-VEGF antibody.
Patent NZ-720726-A (NZ)
Title: Novel carboxamides, method for the production thereof, pharmaceutical preparations comprising them, and use thereof for producing medicaments
Inventor: BOTHE ULRICH
IPC: C07D401/14
Filed: 2014-12-16
Abstract: The invention relates to a 6-substituted indazoles of formula (I) with carboxamide side chains, method for the production thereof, to the use thereof alone or in combinations for treating and/or the prophylaxis of diseases and to the use thereof for producing medicaments for treating and/or the prophylaxis of diseases, in particular for treating and/or the prophylaxis of endometriosis, preventing lymphomas, macular degeneration, COPD and psoriasis.
Patent NZ-722213-A (NZ)
Title: Method for generating high-titer hepatitis e virus stocks and titration assay for hepatitis e virus
Inventor: HOTTA JOANN
IPC: C12N5/09
Filed: 2016-07-15
Abstract: Provided herein are the use of polybrene as an additive in cell culture medium used in methods for the generation of high-titer hepatitis E virus stocks and assays for titration of hepatitis E virus. Also provided are a cell culture medium containing polybrene for high-titer HEV generation, a method for determining the presence and/or the level of HEV in a sample, and an HEV titration assay using polybrene.
Patent NZ-735216-A (NZ)
Title: Oral solid cannabinoid formulations, methods for producing and using thereof
Inventor: SACKS HAGIT
IPC: A61K47/42
Filed: 2017-02-09
Abstract: A gelatin matrix pellet comprising a pre-defined amount of an active ingredient homogenously distributed therein in the absence of a water-miscible solvent that solubilizes and homogenizes the active ingredient. The active ingredient comprising at least one synthetic, semi-synthetic or natural cannabinoid, an extract of a cannabis plant, a combination of cannabis plant constituents, or a combination thereof, wherein the active ingredient comprises at least one of Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabinol (CBN), Cannabigerol (CBG), Cannabichromene (CBC), Cannabicyclol (CBL), Cannabivarin, (CBV), Tetrahydrocannabivarin (THCV), Cannabidivarin (CBDV), Cannabichromevarin (CBCV), Cannabigerovarin (CBGV), Cannabigerol Monomethyl Ether (CBGM), an acid form, and a combination thereof.